This mechanism is more pronounced in QX302-treated cells compared to TMZ, where SLC7A11 suppression is less pronounced, highlighting a distinct pathway through which QX302 induces ferroptosis in GBM cells. The gene discussed is SLC7A11; the disease is glioblastoma.